Effects of Perfluoroalkyl Substances (PFASs) and Benzo[a]pyrene (BaP) Co-exposure on Phase I Biotransformation in Rainbow Trout (Oncorhynchus Mykiss)

Overview

Journal Fish Physiol Biochem

Specialty Biochemistry

Date 2022 Jun 25

PMID 35752723

Authors

Megan E Solan

Marco E Franco

Ramon Lavado

Affiliations

Soon will be listed here.

Abstract

The presence of perfluoroalkyl substances (PFASs) in the environment, especially in aquatic ecosystems, continues to be a significant concern for human and environmental health. Previous studies have suggested that several PFASs do not undergo biotransformation due to their chemical stability, yet perfluorooctanesulfonic acid (PFOS)- and perfluorooctanoic acid (PFOA)-exposed organisms have presented altered activity of important biotransformation pathways. Given the fundamental role of biotransformation in biological organisms and the significant distribution of PFAS in aquatic environments, the present study investigated the influence of PFOA and PFOS on phase I biotransformation enzymes in vitro using the rainbow trout liver RTL-W1 cell line and in vivo using juvenile rainbow trout. Cells and fish were exposed and co-exposed to environmentally relevant concentrations of PFOA, PFOS, and benzo[a]pyrene (BaP), for 72 h and 10 days, respectively, prior to measurements of cytotoxicity and biotransformation ability through measurements of CYP1A1-, CYP1A2-, and CYP3A4-like activities. Our results indicate that exposure to PFAS-BaP binary mixtures altered CYP1A-like activity in vivo; however, those alterations were not observed in vitro. Similarly, while BaP did not significantly induce CYP3A4 in vivo, exposure to the PFAS led to significantly lower enzymatic activity relative to basal levels. These observations may have implications for organisms simultaneously exposed to PFASs and other environmental pollutants for which biotransformation is necessary, especially in detoxification mechanisms. Furthermore, the interference with biotransformation pathways could potentially predispose exposed organisms to a compromised physiology, which may increase their vulnerability to other stressors and erode their survival fitness.

References

Ankley G, Cureton P, Hoke R, Houde M, Kumar A, Kurias J . Assessing the Ecological Risks of Per- and Polyfluoroalkyl Substances: Current State-of-the Science and a Proposed Path Forward. Environ Toxicol Chem. 2020; 40(3):564-605. PMC: 7984443. DOI: 10.1002/etc.4869. View

Booc F, Thornton C, Lister A, MacLatchy D, Willett K . Benzo[a]pyrene effects on reproductive endpoints in Fundulus heteroclitus. Toxicol Sci. 2014; 140(1):73-82. PMC: 4133586. DOI: 10.1093/toxsci/kfu064. View

Bradford M . A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976; 72:248-54. DOI: 10.1016/0003-2697(76)90527-3. View

Conder J, Hoke R, de Wolf W, Russell M, Buck R . Are PFCAs bioaccumulative? A critical review and comparison with regulatory criteria and persistent lipophilic compounds. Environ Sci Technol. 2008; 42(4):995-1003. DOI: 10.1021/es070895g. View

Connors K, Du B, Fitzsimmons P, Hoffman A, Chambliss C, Nichols J . Comparative pharmaceutical metabolism by rainbow trout (Oncorhynchus mykiss) liver S9 fractions. Environ Toxicol Chem. 2013; 32(8):1810-8. DOI: 10.1002/etc.2240. View

Cordner A, De La Rosa V, Schaider L, Rudel R, Richter L, Brown P . Guideline levels for PFOA and PFOS in drinking water: the role of scientific uncertainty, risk assessment decisions, and social factors. J Expo Sci Environ Epidemiol. 2019; 29(2):157-171. PMC: 6455940. DOI: 10.1038/s41370-018-0099-9. View

De Silva A, Armitage J, Bruton T, Dassuncao C, Heiger-Bernays W, Hu X . PFAS Exposure Pathways for Humans and Wildlife: A Synthesis of Current Knowledge and Key Gaps in Understanding. Environ Toxicol Chem. 2020; 40(3):631-657. PMC: 7906948. DOI: 10.1002/etc.4935. View

Franco M, Lavado R . Applicability of in vitro methods in evaluating the biotransformation of polycyclic aromatic hydrocarbons (PAHs) in fish: Advances and challenges. Sci Total Environ. 2019; 671:685-695. DOI: 10.1016/j.scitotenv.2019.03.394. View

Franco M, Ramirez A, Johanning K, Matson C, Lavado R . In vitro-in vivo biotransformation and phase I metabolite profiling of benzo[a]pyrene in Gulf killifish (Fundulus grandis) populations with different exposure histories. Aquat Toxicol. 2021; 243:106057. DOI: 10.1016/j.aquatox.2021.106057. View

10.

Franco M, Sutherland G, Fernandez-Luna M, Lavado R . Altered expression and activity of phase I and II biotransformation enzymes in human liver cells by perfluorooctanoate (PFOA) and perfluorooctane sulfonate (PFOS). Toxicology. 2019; 430:152339. DOI: 10.1016/j.tox.2019.152339. View

11.

Gerlier D, Thomasset N . Use of MTT colorimetric assay to measure cell activation. J Immunol Methods. 1986; 94(1-2):57-63. DOI: 10.1016/0022-1759(86)90215-2. View

12.

Goeritz I, Falk S, Stahl T, Schafers C, Schlechtriem C . Biomagnification and tissue distribution of perfluoroalkyl substances (PFASs) in market-size rainbow trout (Oncorhynchus mykiss). Environ Toxicol Chem. 2013; 32(9):2078-88. DOI: 10.1002/etc.2279. View

13.

Hagenaars A, Vergauwen L, De Coen W, Knapen D . Structure-activity relationship assessment of four perfluorinated chemicals using a prolonged zebrafish early life stage test. Chemosphere. 2010; 82(5):764-72. DOI: 10.1016/j.chemosphere.2010.10.076. View

14.

Hakkola J, Hukkanen J, Turpeinen M, Pelkonen O . Inhibition and induction of CYP enzymes in humans: an update. Arch Toxicol. 2020; 94(11):3671-3722. PMC: 7603454. DOI: 10.1007/s00204-020-02936-7. View

15.

Jiang Y, Fan X, Wang Y, Chen P, Zeng H, Tan H . Schisandrol B protects against acetaminophen-induced hepatotoxicity by inhibition of CYP-mediated bioactivation and regulation of liver regeneration. Toxicol Sci. 2014; 143(1):107-15. PMC: 4334815. DOI: 10.1093/toxsci/kfu216. View

16.

Jonsson M, Brunstrom B, Ingebrigtsen K, Brandt I . Cell-specific CYP1A expression and benzo[a]pyrene adduct formation in gills of rainbow trout (Oncorhynchus mykiss) following CYP1A induction in the laboratory and in the field. Environ Toxicol Chem. 2004; 23(4):874-82. DOI: 10.1897/03-211. View

17.

Khan E, Bertotto L, Dale K, Lille-Langoy R, Yadetie F, Karlsen O . Modulation of Neuro-Dopamine Homeostasis in Juvenile Female Atlantic Cod ( Gadus morhua) Exposed to Polycyclic Aromatic Hydrocarbons and Perfluoroalkyl Substances. Environ Sci Technol. 2019; 53(12):7036-7044. DOI: 10.1021/acs.est.9b00637. View

18.

Krewski D, Andersen M, Tyshenko M, Krishnan K, Hartung T, Boekelheide K . Toxicity testing in the 21st century: progress in the past decade and future perspectives. Arch Toxicol. 2019; 94(1):1-58. DOI: 10.1007/s00204-019-02613-4. View

19.

Kudo N, Kawashima Y . Toxicity and toxicokinetics of perfluorooctanoic acid in humans and animals. J Toxicol Sci. 2003; 28(2):49-57. DOI: 10.2131/jts.28.49. View

20.

Kunacheva C, Fujii S, Tanaka S, Seneviratne S, Lien N, Nozoe M . Worldwide surveys of perfluorooctane sulfonate (PFOS) and perfluorooctanoic acid (PFOA) in water environment in recent years. Water Sci Technol. 2012; 66(12):2764-71. DOI: 10.2166/wst.2012.518. View